Education
About Us
Working with TipRanks
Follow Us
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
| Sep 24 | Sep 23 | Sep 22 | Sep 21 | Sep 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 18.63K | $ 147.81K | $ 349.94K | $ 483.63K | $ 0.00 |
| Gross Profit | $ 18.63K | $ -11.67M | $ 256.69K | $ -16.15M | $ -58.31K |
| Operating Income | $ -11.85M | $ -18.79M | $ -29.67M | $ -25.09M | $ -24.24M |
| EBITDA | $ -11.85M | $ -18.72M | $ -29.58M | $ -24.99M | $ -24.24M |
| Net Income | $ -7.44M | $ -18.83M | $ -29.77M | $ -25.01M | $ -31.06M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 149.46K | $ 2.27M | $ 3.05M | $ 27.62M | $ 7.35M |
| Total Assets | $ 2.77M | $ 5.43M | $ 5.83M | $ 28.99M | $ 7.99M |
| Total Debt | $ 130.86K | $ 203.91K | $ 255.99K | $ 125.88K | $ 353.25K |
| Net Debt | $ -18.59K | $ -2.07M | $ -2.80M | $ -27.50M | $ -7.00M |
| Total Liabilities | $ 3.26M | $ 5.66M | $ 8.37M | $ 6.73M | $ 4.97M |
| Stockholders' Equity | $ -485.74K | $ -225.98K | $ -2.54M | $ 22.26M | $ 3.02M |
| Cash Flow | |||||
| Free Cash Flow | $ -8.61M | $ -21.79M | $ -28.58M | $ -22.56M | $ -15.69M |
| Operating Cash Flow | $ -8.61M | $ -21.34M | $ -27.69M | $ -22.55M | $ -15.61M |
| Investing Cash Flow | $ -12.00K | $ -443.25K | $ -896.48K | $ -3.62K | $ -76.18K |
| Financing Cash Flow | $ 6.49M | $ 21.01M | $ 4.01M | $ 42.83M | $ 23.01M |